Ronald Todd Plott, Director at Phio Pharmaceuticals Corp. (PHIO), bought 10,000 shares at $1.03 ($10K) on 2026-09-28, disclosed to the SEC on 2026-09-30.
Open-market purchase of $10k PHIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.03 | 5,000 | $5K | 49.8% |
| 2 | $1.04 | 5,000 | $5K | 50.2% |
| Total | $1.03 avg | 10,000 | $10K | 100% |